UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 191

Sortiert nach

Approval Summary: Sunitinib for the Treatment of Imatinib Refractory or Intolerant Gastrointestinal Stromal Tumors and Advanced Renal Cell Carcinoma

Clinical cancer research, 2007-03, Vol.13 (5), p.1367-1373

2007

Link zum Volltext

Verfügbarkeit prüfen

Vorinostat for Treatment of Cutaneous Manifestations of Advanced Primary Cutaneous T-Cell Lymphoma

Clinical cancer research, 2007-04, Vol.13 (8), p.2318-2322

2007

Link zum Volltext

Verfügbarkeit prüfen

Use of patient-reported outcomes (PRO) data to complement exposure–response analysis in early clinical cancer drug development

Journal of patient-reported outcomes, 2023-12, Vol.7 (1), p.116-116, Article 116

2023

Link zum Volltext

Verfügbarkeit prüfen

Utility of a physiologically-based pharmacokinetic (PBPK) modeling approach to quantitatively predict a complex drug-drug-disease interaction scenario for rivaroxaban during the drug review process: implications for clinical practice

Biopharmaceutics & drug disposition, 2012-03, Vol.33 (2), p.99-110

2012

Link zum Volltext

Verfügbarkeit prüfen

Assessing proarrhythmic potential of drugs when optimal studies are infeasible

The American heart journal, 2009-05, Vol.157 (5), p.827-836.e1

2009

Link zum Volltext

Verfügbarkeit prüfen

Population Pharmacokinetic-Based Dosing of Intravenous Busulfan in Pediatric Patients

Journal of clinical pharmacology, 2007-01, Vol.47 (1), p.101-111

2007

Link zum Volltext

Verfügbarkeit prüfen

The Role of SN-38 Exposure, UGT1A128 Polymorphism, and Baseline Bilirubin Level in Predicting Severe Irinotecan Toxicity

Journal of clinical pharmacology, 2007-01, Vol.47 (1), p.78-86

2007

Link zum Volltext

Verfügbarkeit prüfen

Hybrid assays: the next big thing?

Bioanalysis, 2018-07, Vol.10 (13), p.975-977

2018

Link zum Volltext

Verfügbarkeit prüfen

Pemetrexed in Malignant Pleural Mesothelioma

Clinical cancer research, 2005-02, Vol.11 (3), p.982-992

2005

Link zum Volltext

Verfügbarkeit prüfen

Impact of pharmacometrics on drug approval and labeling decisions: a survey of 42 new drug applications

The AAPS journal, 2005-10, Vol.7 (3), p.E503-E512

2005

Link zum Volltext

Verfügbarkeit prüfen

Time dependent pharmacokinetics of pembrolizumab in patients with solid tumor and its correlation with best overall response

Journal of pharmacokinetics and pharmacodynamics, 2017-10, Vol.44 (5), p.403-414

2017

Link zum Volltext

Verfügbarkeit prüfen

Land O’Lakes Workshop on Microsampling: Enabling Broader Adoption

The AAPS journal, 2020-10, Vol.22 (6), p.135-135, Article 135

2020

Link zum Volltext

Verfügbarkeit prüfen

Meeting Report: Metabolites in Safety Testing (MIST) Symposium—Safety Assessment of Human Metabolites: What’s REALLY Necessary to Ascertain Exposure Coverage in Safety Tests?

The AAPS journal, 2013-10, Vol.15 (4), p.970-973

2013

Link zum Volltext

Verfügbarkeit prüfen

Meeting Report: Metabolites in Safety Testing (MIST) Symposium—Safety Assessment of Human Metabolites: What’s REALLY Necessary to Ascertain Exposure Coverage in Safety Tests?

The AAPS journal, 2013-10, Vol.15 (4), p.970-973

2013

Link zum Volltext

Verfügbarkeit prüfen

2010 white paper on recent issues in regulated bioanalysis & global harmonization of bioanalytical guidance

Bioanalysis, 2010-12, Vol.2 (12), p.1945-1960

2010

Link zum Volltext

Verfügbarkeit prüfen

Considerations in Analyzing Single-Trough Concentrations Using Mixed-Effects Modeling

Journal of clinical pharmacology, 2003-12, Vol.43 (12), p.1307-1315

2003

Link zum Volltext

Verfügbarkeit prüfen

Welcome to Bioanalysis

Bioanalysis, 2009-04, Vol.1 (1), p.1-2

Booth, Brian P

2009

Link zum Volltext

Verfügbarkeit prüfen

The 2nd Calibration and Validation Group workshop on recent issues in good laboratory practice bioanalysis

Bioanalysis, 2009-04, Vol.1 (1), p.19-30

2009

Link zum Volltext

Verfügbarkeit prüfen

2009 White Paper on recent issues in regulated bioanalysis from the 3rd Calibration and Validation Group Workshop

Bioanalysis, 2010-01, Vol.2 (1), p.53-68

2010

Link zum Volltext

Verfügbarkeit prüfen

Conference Report: Emerging technology for bioanalysis in the next decade

Bioanalysis, 2012-11, Vol.4 (21), p.2557-2561

2012

Link zum Volltext

Verfügbarkeit prüfen

Abstract 587: Improvement in renal function in patients with multiple myeloma and impaired renal function receiving novel agent induction therapies

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.587-587

2020

Link zum Volltext

Verfügbarkeit prüfen

10th Annual University of Wisconsin Land O'Lakes Bioanalytical Conference

Bioanalysis, 2009-11, Vol.1 (8), p.1397

2009

Link zum Volltext

Verfügbarkeit prüfen

Contribution of Vascular Tissue to the Antiplatelet Activity of Sodium Nitroprusside

Journal of cardiovascular pharmacology, 1998-07, Vol.32 (1), p.129-133

1998

Link zum Volltext

Verfügbarkeit prüfen

Regulation of in vivo whole blood aggregation in rats by calcitonin gene related peptide

Canadian journal of physiology and pharmacology, 1998-07, Vol.76 (7-8), p.811

1998

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 191

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(170)
Mit Volltextzugriff
(153)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(191)
Japanisch
(21)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Approval Summary: Sunitinib for the Treatment of Imatinib Refractory or Intolerant Gastrointestinal Stromal Tumors and Advanced Renal Cell Carcinoma

Vorinostat for Treatment of Cutaneous Manifestations of Advanced Primary Cutaneous T-Cell Lymphoma

Use of patient-reported outcomes (PRO) data to complement exposure–response analysis in early clinical cancer drug development

Utility of a physiologically-based pharmacokinetic (PBPK) modeling approach to quantitatively predict a complex drug-drug-disease interaction scenario for rivaroxaban during the drug review process: implications for clinical practice

Assessing proarrhythmic potential of drugs when optimal studies are infeasible

2011 White paper on recent issues in bioanalysis and regulatory findings from audits and inspections

Population Pharmacokinetic-Based Dosing of Intravenous Busulfan in Pediatric Patients

The Role of SN-38 Exposure, UGT1A128 Polymorphism, and Baseline Bilirubin Level in Predicting Severe Irinotecan Toxicity

Hybrid assays: the next big thing?

Pemetrexed in Malignant Pleural Mesothelioma

Impact of pharmacometrics on drug approval and labeling decisions: a survey of 42 new drug applications

Time dependent pharmacokinetics of pembrolizumab in patients with solid tumor and its correlation with best overall response

Land O’Lakes Workshop on Microsampling: Enabling Broader Adoption

Meeting Report: Metabolites in Safety Testing (MIST) Symposium—Safety Assessment of Human Metabolites: What’s REALLY Necessary to Ascertain Exposure Coverage in Safety Tests?

Meeting Report: Metabolites in Safety Testing (MIST) Symposium—Safety Assessment of Human Metabolites: What’s REALLY Necessary to Ascertain Exposure Coverage in Safety Tests?

2010 white paper on recent issues in regulated bioanalysis & global harmonization of bioanalytical guidance

Considerations in Analyzing Single-Trough Concentrations Using Mixed-Effects Modeling

Welcome to Bioanalysis

The 2nd Calibration and Validation Group workshop on recent issues in good laboratory practice bioanalysis

2009 White Paper on recent issues in regulated bioanalysis from the 3rd Calibration and Validation Group Workshop

Conference Report: Emerging technology for bioanalysis in the next decade

Abstract 587: Improvement in renal function in patients with multiple myeloma and impaired renal function receiving novel agent induction therapies

10th Annual University of Wisconsin Land O'Lakes Bioanalytical Conference

Contribution of Vascular Tissue to the Antiplatelet Activity of Sodium Nitroprusside

Regulation of in vivo whole blood aggregation in rats by calcitonin gene related peptide

Suchergebnisse filtern